Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-06-06

Clinical Trial Update: Reversal of Hypoglycemia Unawareness Using Continuous Glucose Monitoring [NA]

View source ↗

Summary

A clinical trial evaluating continuous glucose monitoring to reverse hypoglycemia unawareness in diabetes mellitus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Stanford University | Conditions: Diabetes Mellitus | NA | Status: WITHDRAWN